Herpes simplex keratitis

Dis Mon. 2014 Jun;60(6):239-46. doi: 10.1016/j.disamonth.2014.03.003.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Ophthalmic
  • Antiviral Agents / administration & dosage*
  • Blindness / prevention & control
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Herpesvirus 1, Human / isolation & purification*
  • Humans
  • Incidence
  • Keratitis, Herpetic / diagnosis*
  • Keratitis, Herpetic / drug therapy*
  • Keratitis, Herpetic / epidemiology
  • Latanoprost
  • Male
  • Monitoring, Physiologic
  • Neuroprotective Agents / administration & dosage
  • Prostaglandins F, Synthetic / administration & dosage
  • Risk Assessment
  • Severity of Illness Index
  • Time Factors

Substances

  • Antiviral Agents
  • Neuroprotective Agents
  • Prostaglandins F, Synthetic
  • Latanoprost